Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
257
-
Total 13F shares, excl. options
-
46.8M
-
Shares change
-
-830K
-
Total reported value, excl. options
-
$2.97B
-
Value change
-
-$41.9M
-
Put/Call ratio
-
0.65
-
Number of buys
-
151
-
Number of sells
-
-94
-
Price
-
$63.50
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2019
302 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q1 2019.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 257 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.8M shares
of 66.6M outstanding shares and own 70.36% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (5.91M shares), BlackRock Inc. (3.97M shares), FRED ALGER MANAGEMENT INC (2.64M shares), LORD, ABBETT & CO. LLC (1.76M shares), FEDERATED INVESTORS INC /PA/ (1.6M shares), WELLINGTON MANAGEMENT GROUP LLP (1.44M shares), EAGLE ASSET MANAGEMENT INC (1.31M shares), TimesSquare Capital Management, LLC (1.25M shares), STATE STREET CORP (1.24M shares), and TWO SIGMA ADVISERS, LP (928K shares).
This table shows the top 257 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.